07:14 AM EDT, 05/14/2024 (MT Newswires) -- (Updates with company comment in second paragraph)

Novo Nordisk A/S ( NVO ) plans to sell bonds for the first time in more than two years to finance programs to increase production of its blockbuster treatments, Bloomberg reported on Monday, citing a person familiar with the matter.

The company is issuing bonds for general corporate purposes and to finance the acquisition of the three sites from Catalent ( CTLT ), Novo Nordisk ( NVO ) told MT newswires.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 133.19, Change: +0.78, Percent Change: +0.59